ALBANY, N.Y., Nov. 30, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO - News), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference in San Francisco, Calif., on Tuesday, December 6, 2011, at 10:40 a.m. Pacific Time. Joseph M. DeVivo, President and Chief Executive Officer of AngioDynamics, will review the Company's business strategy and recent corporate developments.
